WallStreetZenWallStreetZen

NASDAQ: NEPH
Nephros Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NEPH

Based on 1 analyst offering 12 month price targets for Nephros Inc

Min Forecast
$6.00+36.36%
Avg Forecast
$6.00+36.36%
Max Forecast
$6.00+36.36%

Should I buy or sell NEPH stock?

Based on 1 analyst offering ratings for Nephros Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their NEPH stock forecasts and price targets.

NEPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-08

1 of 1

Forecast return on equity

Is NEPH forecast to generate an efficient return?

Company
6.5%
Industry
17.4%
Market
331.59%
NEPH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NEPH forecast to generate an efficient return on assets?

Company
4.91%
Industry
12.92%
NEPH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NEPH earnings per share forecast

What is NEPH's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$0.05-67.21%
Avg 2 year Forecast
$0.06-56.29%
NEPH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

NEPH revenue forecast

What is NEPH's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$17.6M-1.76%
Avg 2 year Forecast
$19.4M+8.22%
NEPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NEPH earnings growth forecast

How is NEPH forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
-67.21%
Industry
226.36%
Market
2,926.95%
NEPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NEPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NEPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NEPH revenue growth forecast

How is NEPH forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
-1.76%
Industry
7.9%
Market
1,458.08%
NEPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NEPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NEPH vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
NEPH$4.40$6.00+36.36%Strong Buy
ZJYL$0.26N/AN/A
POCI$4.33N/AN/A
HBIO$0.66$2.00+203.03%Buy
MLSS$0.33N/AN/A
View Top Medical Stocks

Nephros Stock Forecast FAQ

Is Nephros Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: NEPH) stock is to Strong Buy NEPH stock.

Out of 1 analyst, 1 (100%) are recommending NEPH as a Strong Buy, 0 (0%) are recommending NEPH as a Buy, 0 (0%) are recommending NEPH as a Hold, 0 (0%) are recommending NEPH as a Sell, and 0 (0%) are recommending NEPH as a Strong Sell.

If you're new to stock investing, here's how to buy Nephros stock.

What is NEPH's earnings growth forecast for 2025-2026?

(NASDAQ: NEPH) Nephros's forecast annual earnings growth rate of -67.21% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 226.36%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,926.95%.

Nephros's earnings in 2025 is $1,481,000.On average, 4 Wall Street analysts forecast NEPH's earnings for 2025 to be $487,765, with the lowest NEPH earnings forecast at $416,566, and the highest NEPH earnings forecast at $557,901.

In 2026, NEPH is forecast to generate $650,353 in earnings, with the lowest earnings forecast at $624,849 and the highest earnings forecast at $669,481.

What is NEPH's revenue growth forecast for 2025-2026?

(NASDAQ: NEPH) Nephros's forecast annual revenue growth rate of -1.76% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,458.08%.

Nephros's revenue in 2025 is $17,930,000.On average, 4 Wall Street analysts forecast NEPH's revenue for 2025 to be $187,178,394, with the lowest NEPH revenue forecast at $178,039,447, and the highest NEPH revenue forecast at $194,617,072.

In 2026, NEPH is forecast to generate $206,200,157 in revenue, with the lowest revenue forecast at $198,123,878 and the highest revenue forecast at $212,267,993.

What is NEPH's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: NEPH) forecast ROA is 4.91%, which is lower than the forecast US Medical Instruments & Supplies industry average of 12.92%.

What is NEPH's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NEPH price target, the average NEPH price target is $6.00, with the highest NEPH stock price forecast at $6.00 and the lowest NEPH stock price forecast at $6.00.

The Wall Street analyst predicted that Nephros's share price could reach $6.00 by Aug 8, 2026. The average Nephros stock price prediction forecasts a potential upside of 36.36% from the current NEPH share price of $4.40.

What is NEPH's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: NEPH) Nephros's current Earnings Per Share (EPS) is $0.14. On average, analysts forecast that NEPH's EPS will be $0.05 for 2025, with the lowest EPS forecast at $0.04, and the highest EPS forecast at $0.05. In 2026, NEPH's EPS is forecast to hit $0.06 (min: $0.06, max: $0.06).

What is NEPH's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: NEPH) forecast ROE is 6.5%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.